These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 586006)

  • 1. [Drug information: agents in the treatment of neoplastic diseases. Therapeutic main group: cytostatic agents. 2. Alkylating agents].
    Lumholtz IB
    Sygeplejersken; 1977 May; 77(18):15. PubMed ID: 586006
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug information. Agents for the treatment of neoplastic diseases. Therapeutic main group: cytostatic agents. 7].
    Lumholtz IB
    Sygeplejersken; 1977 Jul; 77(28):11. PubMed ID: 587540
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug information: agents in the treatment of neoplastic diseases. Therapeutic main group: cytostatic agents. 1].
    Lumholtz IB
    Sygeplejersken; 1977 Apr; 77(16):13. PubMed ID: 585992
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug information. Agents for treatment of neoplastic diseases. Therapeutic main group: cytostatic agents. 4].
    Lumholtz IB
    Sygeplejersken; 1977 Jun; 77(22):11-2. PubMed ID: 586893
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug information. Agents for the treatment of neoplastic diseases. Therapeutic main group: cytostatic agents. 6. Hormones].
    Lumholtz IB
    Sygeplejersken; 1977 Jul; 77(26):13-4. PubMed ID: 587531
    [No Abstract]   [Full Text] [Related]  

  • 6. [Alkylating nucleosides. Synthesis and cytostatic activity of new types of halomethyl-substituted nucleosides].
    Pérez Méndez-Castrillón MP
    Rev Esp Oncol; 1984; 31(1):7-13. PubMed ID: 6545430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulmonary changes caused by cytostatic drugs].
    Akoun G; Milleron B; Mayaud C
    Ann Med Interne (Paris); 1985; 136(8):671-6. PubMed ID: 3914227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Membrane mechanisms of the effect of alkylating cytostatic agents].
    Mukhin VV; Poda GI; Luĭk AI; Baldenkov GN
    Biull Eksp Biol Med; 1990 Apr; 109(4):351-3. PubMed ID: 2386826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthesis, cytostatic activity and mechanism of action of N-glycosylhalomethylazoles. A new class of alkylating agents].
    Alonso G; Alonso R; Camarasa MJ; Contreras A; García López MT; de las Heras FG; Herranz R; Sánchez-Pérez RM
    Rev Esp Oncol; 1982; 29(4):603-7. PubMed ID: 6927609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug information: agents for the treatment of neoplastic diseases. Therapeutic main group: cytostatica. 3].
    Lumholtz IB
    Sygeplejersken; 1977 May; 77(20):19. PubMed ID: 586884
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms for the modulation of alkylating activity by the quinone group in quinone alkylating agents.
    Begleiter A; Leith MK; Pan SS
    Mol Pharmacol; 1991 Sep; 40(3):454-8. PubMed ID: 1896030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guidelines in the therapy of various neoplastic diseases with cytostatic drugs].
    Bollag W
    Praxis; 1969 Jun; 58(22):703-7. PubMed ID: 5258076
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cytostatic drugs. 1: Platinum compounds, alkylating and intercalating cytostatic drugs].
    Bauch HJ
    Med Monatsschr Pharm; 1989 Jan; 12(1):8-20. PubMed ID: 2643766
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cytostatic treatment of autoimmune diseases].
    Gjone E
    Tidsskr Nor Laegeforen; 1969 Mar; 89(6):387-90. PubMed ID: 5792114
    [No Abstract]   [Full Text] [Related]  

  • 15. Preclinical studies and clinical correlation of the effect of alkylating dose.
    Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY
    Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.
    Teicher BA; Cucchi CA; Lee JB; Flatow JL; Rosowsky A; Frei E
    Cancer Res; 1986 Sep; 46(9):4379-83. PubMed ID: 3731096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of neoplastic transformation and DNA single-strand breaks in C3H/10T1/2 clone 8 cells by polycyclic hydrocarbons and alkylating agents.
    Lubet RA; Kiss E; Gallagher MM; Dively C; Kouri RE; Schechtman LM
    J Natl Cancer Inst; 1983 Nov; 71(5):991-7. PubMed ID: 6316014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinogenicity of alkylating cytostatic drugs: conclusions and directions for future research.
    Kaldor J; Schmähl D
    IARC Sci Publ; 1986; (78):321-3. PubMed ID: 3583396
    [No Abstract]   [Full Text] [Related]  

  • 19. Carcinogenicity of alkylating cytostatic drugs. Proceedings of a symposium. Heidelberg, Federal Republic of Germany, 25-27 November 1985.
    IARC Sci Publ; 1986; (78):1-338. PubMed ID: 3583383
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
    Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
    Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.